High prevalence of resistance to third-generation cephalosporins detected among clinical isolates from sentinel healthcare facilities in Lagos, Nigeria.
Antibiotics
Antimicrobial resistance
Clinical isolates
ESBL genes
MecA
Nigeria
Resistance genes
Staphylococcus aureus
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
08 11 2022
08 11 2022
Historique:
received:
09
05
2022
accepted:
17
10
2022
entrez:
9
11
2022
pubmed:
10
11
2022
medline:
11
11
2022
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) in bacterial pathogens is a worldwide concern that demands immediate attention. Most information on AMR originates from high-income countries and little is known about the burden in Africa, particularly Nigeria. Using four sentinel sites (General hospitals) in Lagos State, this study sought to estimate the burden of AMR. This is a hospital-based surveillance using secondary health care centres. Four sites were randomly selected and included in the study. Clinical isolates were collected over a period of 6 months for each site from August 2020 to March 2021. All isolates were characterised and analysed for resistance to 15 antibiotics using the Kirby-Baur method. Multiplex PCR assay was used for the detection of Extended spectrum beta lactamase genes. Data analysis was done using SPSS version 27.0. Four hundred and ninety-nine (499) patients consented and participated in this study, consisting of 412 (82.6%) females and 87 (17.4%) males. The mean age ± SD of the participants was 33.9 ± 13.8 with a range of 1-89 years. The majority (90.8%) of the participants were outpatients. Two hundred and thirty-two (232) isolates were obtained from 219 samples, comprising of 120 (51.7%) Gram positive and 112 (48.3%) Gram negative organisms. Key bacterial pathogens isolated from this study included Staphylococcus aureus (22.8%), Escherichia coli (16.4%), Staphylococcus spp. (15.9%), Enterococcus spp. (7.3%) and Klebsiella pneumoniae (6.5%). There was high prevalence of multi-drug resistance (79.3%) among the isolates with 73.6% of Staphylococcus aureus phenotypically resistant to methicillin and 70% possessed the MecA gene. 76.5% of Enterococcus spp. isolated were Vancomycin resistant. Overall, resistance to Cephalosporins was most frequently/commonly observed (Cefotaxime 87.5%). A high incidence of AMR was identified in clinical bacteria isolates from selected general hospitals in Lagos State, highlighting the necessity for the implementation of national action plans to limit the prevalence of AMR. Surveillance via collection of isolates has a lot of promise, especially in resource-limited environments.
Sections du résumé
BACKGROUND
Antimicrobial resistance (AMR) in bacterial pathogens is a worldwide concern that demands immediate attention. Most information on AMR originates from high-income countries and little is known about the burden in Africa, particularly Nigeria. Using four sentinel sites (General hospitals) in Lagos State, this study sought to estimate the burden of AMR.
METHODS
This is a hospital-based surveillance using secondary health care centres. Four sites were randomly selected and included in the study. Clinical isolates were collected over a period of 6 months for each site from August 2020 to March 2021. All isolates were characterised and analysed for resistance to 15 antibiotics using the Kirby-Baur method. Multiplex PCR assay was used for the detection of Extended spectrum beta lactamase genes. Data analysis was done using SPSS version 27.0.
RESULTS
Four hundred and ninety-nine (499) patients consented and participated in this study, consisting of 412 (82.6%) females and 87 (17.4%) males. The mean age ± SD of the participants was 33.9 ± 13.8 with a range of 1-89 years. The majority (90.8%) of the participants were outpatients. Two hundred and thirty-two (232) isolates were obtained from 219 samples, comprising of 120 (51.7%) Gram positive and 112 (48.3%) Gram negative organisms. Key bacterial pathogens isolated from this study included Staphylococcus aureus (22.8%), Escherichia coli (16.4%), Staphylococcus spp. (15.9%), Enterococcus spp. (7.3%) and Klebsiella pneumoniae (6.5%). There was high prevalence of multi-drug resistance (79.3%) among the isolates with 73.6% of Staphylococcus aureus phenotypically resistant to methicillin and 70% possessed the MecA gene. 76.5% of Enterococcus spp. isolated were Vancomycin resistant. Overall, resistance to Cephalosporins was most frequently/commonly observed (Cefotaxime 87.5%).
CONCLUSION
A high incidence of AMR was identified in clinical bacteria isolates from selected general hospitals in Lagos State, highlighting the necessity for the implementation of national action plans to limit the prevalence of AMR. Surveillance via collection of isolates has a lot of promise, especially in resource-limited environments.
Identifiants
pubmed: 36348431
doi: 10.1186/s13756-022-01171-2
pii: 10.1186/s13756-022-01171-2
pmc: PMC9640893
doi:
Substances chimiques
Cefotaxime
N2GI8B1GK7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
134Informations de copyright
© 2022. The Author(s).
Références
Can J Infect Dis Med Microbiol. 2019 Feb 06;2019:8321834
pubmed: 30881532
Antimicrob Resist Infect Control. 2013 Nov 18;2:31
pubmed: 24237856
J Clin Microbiol. 2010 Jan;48(1):120-3
pubmed: 19889896
Infect Drug Resist. 2015 Nov 18;8:379-89
pubmed: 26604806
Molecules. 2012 Dec 24;18(1):204-24
pubmed: 23262449
Mediterr J Hematol Infect Dis. 2019 Jul 01;11(1):e2019041
pubmed: 31308917
Antimicrob Resist Infect Control. 2020 May 20;9(1):72
pubmed: 32434552
Afr J Lab Med. 2016 Oct 31;5(3):482
pubmed: 28879138
J Clin Diagn Res. 2016 Feb;10(2):DC07-10
pubmed: 27042460
Iran J Pharm Res. 2015 Fall;14(4):1257-62
pubmed: 26664394
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
Clin Infect Dis. 2016 May 15;62(10):e51-77
pubmed: 27080992
J Antimicrob Chemother. 2014 Sep;69(9):2337-53
pubmed: 24879668
Afr Health Sci. 2010 Sep;10(3):253-65
pubmed: 21327137
J Clin Microbiol. 1998 Mar;36(3):618-23
pubmed: 9508283
Clin Microbiol Infect. 2013 Sep;19(9):860-8
pubmed: 23039210
J Clin Microbiol. 2000 Jan;38(1):7-12
pubmed: 10618054
Ann Clin Microbiol Antimicrob. 2015 Apr 12;14:23
pubmed: 25890291
Diagn Microbiol Infect Dis. 2017 Jan;87(1):45-48
pubmed: 27773544
Antibiotics (Basel). 2021 Feb 01;10(2):
pubmed: 33535654
Clin Infect Dis. 2014 Aug 1;59(3):390-7
pubmed: 24795331
Bull World Health Organ. 2016 Apr 1;94(4):267-75
pubmed: 27034520
Can J Infect Dis Med Microbiol. 2017;2017:2191532
pubmed: 28154581
Sci Rep. 2020 Sep 7;10(1):14737
pubmed: 32895433
Trop Med Int Health. 2011 Feb;16(2):152-61
pubmed: 21138507